PT233 - JR Rahn - LSD, ADHD, and Decriminalization

<div class="">In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD. </div> <div class=""> </div> <div class=""><a class="" href= "http://www.psychedelicstoday.com/">www.psychedelicstoday.com</a></div> <p><!-- /wp:cgb/block-libsyn-podcasting-gutenberg --></p>